Human T-cell leukemia virus type I (HTLV-I) is the causative agent of adult T-cell leukaemia (ATL) and HTLV-I-associated myelopathy or tropical spastic paraparesis (HAM/TSP) (Hinuma et al., 1981) . The major target of HTLV-I in vivo is CD4-positive T-cells (Popovic et al., 1983) . It is believed that the transmission of HTLV-I mainly occurs from infected lymphocytes to uninfected cells by their direct contact, because the infectious viral particles are hardly detected in peripheral blood of HTLV-I carriers including ATL and HAM/TSP patients (Igakura et al., 2003) . Virological synapsemediated cell-cell transmission of HTLV-I is also reported (Thoulouze & Alcover, 2011) . On the other hand, viral particles of HTLV-I without producer cells (i.e. cell-free HTLV-I) are shown to infect some human cells (Clapham et al., 1983) . However, the cell system to monitor the events in the life cycle of cell-free HTLV-I has not been established. So far, co-cultivation and syncytia formation assays have been frequently used to detect HTLV-I transmission in vitro (Hoshino et al., 1983) . However, these assays cannot distinguish newly synthesized products of HTLV-I in the infected cells from those already existing in donor cells. Pseudotype assay cannot analyse the events after the entry step of HTLV-I (Clapham et al., 1984) . Thus, these features of the ready-made assay systems have prevented us from analysing the precise infection steps of cell-free HTLV-I. To overcome this problem, we developed a new cell system reported here.
We used a feline kidney cell line, 8C (Fischinger et al., 1973) , as material, since the cells have been shown to be susceptible to HTLV-I (Haraguchi et al., 1994) . Another material was the tax1 gene encoding the Tax1 protein, which acts as a transactivator for viral and cellular genes. For Tax1 activity, cAMP-responsive element-binding/activating transcription factor (CREB/ATF), nuclear factor kappa B (NF-kB) and serum response factor (SRF) should bind their corresponding sequences in HTLV-I long terminal repeat (LTR) such as a 21 bp repeat, NF-kB element and serum response element (SRE), respectively (Azran et al., 2004) . Hence, we supposed that the susceptibility of 8C cells to HTLV-I will be enhanced if the cells are transduced with the tax1 gene. We made 8C cells expressing wild-type Tax1 protein, 8C/TaxWT cells, by transduction of the tax1 gene. Similarly, 8C cells having Tax1 activity-defective mutants, Tax410 and TaxM22, were also established, and designated 8C/Tax410 and 8C/TaxM22 cells, respectively. Tax410 causes a defect of the response associated with CREB/ATF, NF-kB and SRF. TaxM22 cannot react with NF-kB (Akagi et al., 1997) . In 8C/TaxWT, 8C/Tax410 and 8C/TaxM22 cells, similar amounts of Tax1 proteins were detected by Western blot analysis using an anti-Tax1 mouse mAb, TAXY7 (Tanaka et al., 1991) (Fig. 1a) . To monitor Tax1-dependent transcription in 8C/TaxWT, 8C/Tax410 and 8C/TaxM22 cells, a luciferase assay using reporter plasmids, p21x5-Luc, pNF-kBx4-Luc or pCArG-Luc was carried out as described previously (Akagi et al., 1997) . When p21x5-Luc plasmid was transduced into those cells, the luciferase activities were 20-and 9-times higher in 8C/TaxWT and 8C/TaxM22 cells than those in 8C and 8C/Tax410 cells, respectively. In contrast, when pNF-kBx4-Luc or pCArG-Luc plasmid was used, the activities were similar among all cells (Fig. 1b) . These results indicate that transcription from the HTLV-I LTR in 8C/ TaxWT and 8C/TaxM22 cells is activated depending on 21 bp repeats and not on the NF-kB element or SRE.
Firstly, we checked the effect of the Tax1 protein on the entry efficiency of HTLV-I into 8C cells. 8C, 8C/TaxWT, 8C/Tax410 and 8C/TaxM22 cells were exposed to serially diluted Melanesian HTLV-I strain, HTLV-I Mel5 (Gessain et al., 1993) , produced by 8C/HTLV-I Mel5 cells (Hoshino et al., 1993) or a cosmopolitan HTLV-I strain, HTLV-I MT-2 (Miyoshi et al., 1981) , produced by PG-4/HTLV-I MT-2 cells and cultured for 24 h. We made PG-4/HTLV-I MT-2 cells by co-cultivating feline PG-4 cells with an HTLV-I-producing rabbit T-cell line, Ra-1 (Miyoshi et al., 1985) , transformed with the MT-2 strain. HTLV-I DNA in 8C, 8C/TaxWT, 8C/ Tax410 and 8C/TaxM22 cells was detected by PCR using primers of the HTLV-I gag gene: 59-GGCTGGAAGAC-TAACACTTT-39 (sense, 1866-1846) and 59-GAGCCTTA- CCACACCTTCGT-39 (antisense, 1637-1657) (GenBank accession no. J02029). The intensities of the bands were similar among those cells (Fig. 1c) , indicating that the entry efficiencies of the cell-free HTLV-I into those cells are similar and that the Tax1 protein has no effects on the molecules involved in syncytia formation such as glucose transporter-1 (Manel et al., 2003) or intercellular adhesion molecule-1 (Daenke et al., 1999) . Secondly, we accessed the susceptibility of 8C and 8C/ TaxWT cells to cell-free HTLV-I by the transcription levels of viral mRNAs. These cells were exposed to the HTLV-I Mel5 strain. Viral mRNAs in these cells were measured by RT-PCR using the gag primers described above. The gag DNA band in 8C/TaxWT cells was considerably stronger than that in 8C cells, confirming that the Tax1 in 8C/TaxWT cells can enhance the gag gene transcription of infected HTLV-I (Fig.  1d) . We also analysed the susceptibility of 8C, 8C/TaxWT, 8C/Tax410 and 8C/TaxM22 cells to the cell-free HTLV-I Mel5 or HTLV-I MT-2 strain by indirect immunofluorescence assay (IFA) using an HTLV-I carrier serum as the first antibody. Moreover, HTLV-I antigen-positive cells were detected in 8C/TaxWT and 8C/TaxM22 cells rather than in 8C and 8C/ Tax410 cells (Fig. 1e) . Numerous large cells with HTLV-I antigens were observed in 8C/TaxWT cells on day 6 after infection ( Fig. 1f) Thirdly, we also checked the susceptibilities of 8C/TaxWT, 8C/Tax410 and 8C/TaxM22 cells to cell-free HTLV-I by a syncytia formation assay. These cells were exposed to the HTLV-I Mel5 or HTLV-I MT-2 strain and cultured for 6 days. Obviously, large syncytia containing 10 or more nuclei were efficiently induced in 8C/TaxWT and 8C/TaxM22 cells. Syncytia were already detected in 8C/TaxWT cells infected with the HTLV-I MT-2 strain on day 4 after infection (Fig. 2a) . It should be noted that the sizes of the syncytia in 8C/ TaxWT and 8C/TaxM22 cells infected with the HTLV-I Mel5 strain were apparently smaller than those infected with the HTLV-I MT-2 strain on day 6 after infection (Fig. 2c) . The rate of formation of the syncytia with 10 or more nuclei were 20 % or less in 8C/TaxWT cells infected with the HTLV-I Mel5 strain, while it was 90 % or more in cells infected with the HTLV-I MT-2 strain (Fig. 2b) , suggesting that the genetic differences between the HTLV-I Mel5 and HTLV-I MT-2 strains may affect their efficiency. Syncytial plaques were induced in the 8C/TaxWT cells infected with the HTLV-I Mel5 strain (Fig. 3a) . The numbers of plaques proportionally decreased in accordance with viral dilutions (Fig. 3b) . 8C/TaxWT cells were exposed to the HTLV-I Mel5 strain treated with serially diluted HTLV-I carrier serum for 30 min. Plaque formation was completely blocked by 0.5 % (v/v) HTLV-I carrier serum (Fig. 3c) . 8C/TaxWT cells were treated with 39-azido-39-deoxythymidine (AZT) for 3 h and exposed to the HTLV-I Mel5 strain. No syncytia were detected at 1.0 mg AZT ml 21 (Fig. 3d) . These results suggested that the syncytial plaques in 8C/TaxWT cells were evidently induced by infection of cell-free HTLV-I. 8C/TaxWT cells will contribute to clarify unknown virological features of HTLV-I. On day 24 after infection, when most of the 8C/TaxWT cells had already been infected with the HTLV-I Mel5 or HTLV-I MT-2 as strain, the amounts of Gag p19 protein were more in the cells with HTLV-I MT-2 than those with HTLV-I Mel5 as identified by Western blotting using an anti-Gag p19 mouse mAb, GIN-7 (Tanaka et al., 1986) (Fig. 3e) . On the other hand, amounts of gag DNA were more in the cells infected with the HTLV-I Mel5 strain than those infected with the HTLV-I MT-2 strain as identified by PCR (Fig. 3f) . These results suggest that these HTLV-I strains may have different virological features. We also found that the cell-free HTLV-I can easily transform 8C/TaxWT cells to the persistently infected cells with HTLV-I. The enhanced production of anti-HTLV-I antibodies, activation of T-cells, and large amounts of viral DNA in peripheral blood have frequently been observed in HAM/TSP patients, suggesting that the HTLV-I infection is active in these patients (Kubota et al., 1993) . Virological features of HTLV-I in HAM/TSP patients may be different from those in ATL patients.
Thus, a new system, 8C/TaxWT cells, which enables us to easily analyse the infection processes of cell-free HTLV-I, has been established. More information from the studies using this cell system and cell-free HTLV-I will give us some clues to understanding the transmission and developing mechanisms of ATL and several HTLV-I-related diseases. subjected to Western blot analysis using an anti-p19 mouse mAb, GIN-7 (Tanaka et al., 1986) . (f) HTLV-I DNA in 8C/TaxWT cells infected with HTLV-I Mel5 or HTLV-I MT-2 . 8C/TaxWT cells were exposed to the HTLV-I Mel5 or HTLV-I MT-2 strain, cultured for 24 days and lysed. The lysates (5¾10 4 cells) were five times serially diluted and subjected to PCR using gag primers.
